Dental and Oral Diseases with MCC DRG Reimbursement Guide

DRG 157 encompasses dental and oral disease hospitalizations with a Major Complication or Comorbidity that substantially increases clinical complexity. Understanding this Diagnosis-Related Group is important for Medicare inpatient reimbursement because the Major Complication or Comorbidity status drives higher payment for increased resource utilization.

DRG 157 Overview

DRG 157 covers inpatient hospital cases for dental and oral diseases complicated by a Major Complication or Comorbidity that significantly increases resource use, such as severe infections, extensive surgical interventions, or systemic sequelae. This Diagnosis-Related Group groups patients whose oral or maxillofacial conditions require heightened levels of care and longer hospital stays. It matters for Medicare payment because the presence of a Major Complication or Comorbidity elevates relative reimbursement to reflect the greater intensity of services and costs associated with managing these complex inpatient cases.

Acute surgical and perioperative care trials assessing optimized management protocols for complex dental and oral infections with major complications: these studies enroll hospitalized patients with severe odontogenic infections, maxillofacial trauma, or postoperative infections requiring operative intervention and intensive inpatient care, comparing timing of surgery, airway management strategies, adjunctive antimicrobial regimens, and perioperative critical-care support. They address immediate mortality/morbidity risks and resource use in the inpatient episode, providing evidence relevant to providers for care pathways and to payers for LOS, complication rates, and appropriate reimbursement for high-acuity admissions.
Comparative effectiveness studies of inpatient multidisciplinary care models for patients with significant comorbidities and oral disease-related complications: trials compare outcomes between standard surgical/medical management versus coordinated teams (oral/maxillofacial surgery, ENT, infectious disease, anesthesiology, dental specialists, and social work) in adults with complex dental disease and major complications (eg, deep space neck infections, osteomyelitis, or immunocompromised hosts). These studies focus on readmissions, complication reduction, functional outcomes, and cost-effectiveness, informing clinicians and hospital administrators about best organizational strategies and payers about value-based approaches for high-cost DRG 157 cases.
Post-discharge and longitudinal outcome studies examining rehabilitation, oral function, and healthcare utilization after inpatient treatment for severe dental and oral disease with major complications: prospective cohort studies follow patients after discharge to assess wound healing, need for reconstructive procedures, nutritional status, long-term infection control, and subsequent ED visits or rehospitalizations, with stratification by age, comorbidity, and social determinants. Findings inform discharge planning, outpatient care coordination, and prevention programs to reduce readmissions and downstream costs, making the evidence directly useful to providers managing follow-up care and payers interested in reducing post-acute expenditures.

Acute surgical and perioperative care trials assessing optimized management protocols for complex dental and oral infections with major complications: these studies enroll hospitalized patients with severe odontogenic infections, maxillofacial trauma, or postoperative infections requiring operative intervention and intensive inpatient care, comparing timing of surgery, airway management strategies, adjunctive antimicrobial regimens, and perioperative critical-care support. They address immediate mortality/morbidity risks and resource use in the inpatient episode, providing evidence relevant to providers for care pathways and to payers for LOS, complication rates, and appropriate reimbursement for high-acuity admissions.
Comparative effectiveness studies of inpatient multidisciplinary care models for patients with significant comorbidities and oral disease-related complications: trials compare outcomes between standard surgical/medical management versus coordinated teams (oral/maxillofacial surgery, ENT, infectious disease, anesthesiology, dental specialists, and social work) in adults with complex dental disease and major complications (eg, deep space neck infections, osteomyelitis, or immunocompromised hosts). These studies focus on readmissions, complication reduction, functional outcomes, and cost-effectiveness, informing clinicians and hospital administrators about best organizational strategies and payers about value-based approaches for high-cost DRG 157 cases.
Post-discharge and longitudinal outcome studies examining rehabilitation, oral function, and healthcare utilization after inpatient treatment for severe dental and oral disease with major complications: prospective cohort studies follow patients after discharge to assess wound healing, need for reconstructive procedures, nutritional status, long-term infection control, and subsequent ED visits or rehospitalizations, with stratification by age, comorbidity, and social determinants. Findings inform discharge planning, outpatient care coordination, and prevention programs to reduce readmissions and downstream costs, making the evidence directly useful to providers managing follow-up care and payers interested in reducing post-acute expenditures.

OpenPayer

Summary & Overview

Dental and Oral Diseases with MCC: Inpatient Reimbursement Overview

DRG 157 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes